United States · Funded startup

Who invested in EchoNous

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$35Mraised across 1 round since 2017, from 1 source

Latest round
Round, $35MSept 2017
Investors
1
See who backed them

The rounds

  1. Sept 2017
    Round$35M

    Reported by FinSMEs

Founders and team

From EchoNous's own website and the SEC filings it signed: 10 on the team.

  • Tony TitusCEO
  • Mike SchuhCFo
  • Shannon Eubankscoo
  • Todd Willsiecto
  • Brooke BrandtVP, North America Sales
  • Jim LucasVP, Emea
  • Simon KimVP, Commercial operations
  • Takatsuna KitagawaVP, Japan Sales
  • Rebecca PennGeneral Counsel
  • Graham CoxExecutive Officeri

On the board, as filediDavid KhoDoug LogigianRichard GumerThomas DeSouza

Everyone who backed them

KKRVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists EchoNous as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

TEAMFundVC firmPer its own site

Quick answers about EchoNous

Who invested in EchoNous?

EchoNous's investors include KKR.

How much has EchoNous raised?

EchoNous has raised $35M across 1 round since 2017.

When did EchoNous last raise?

EchoNous's most recent round was an Undisclosed round of $35M in Sept 2017.

What was EchoNous's biggest round?

Its most recent round, $35M in Sept 2017, is also its largest on record.

Who backed EchoNous first?

EchoNous's first round on record, in Sept 2017, was backed by KKR.

What stage is EchoNous at?

EchoNous's latest named round is an Undisclosed round, in Sept 2017.

Where is EchoNous based?

EchoNous is based in the United States.

Companies like EchoNous

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.